Metser, Ur

How to Design AI-Driven Clinical Trials in Nuclear Medicine

Delso, G., Cirillo, D., Kaggie, J. D., Valencia, A., Metser, U., & Veit-Haibach, P. (2021) · Seminars in Nuclear Medicine

Artificial Intelligence in Healthcare and EducationMedical Imaging Techniques and Applications

Cited by 36

Training improves the interobserver agreement of the expert positron emission tomography review panel in primary mediastinal B‐cell lymphoma: interim analysis in the ongoing International Extranodal Lymphoma Study Group‐37 study

Ceriani, L., Barrington, S., Biggi, A., Malkowski, B., Metser, U., Versari, A., Martelli, M., Davies, A., Johnson, P. W., Zucca, E., et al. (2017) · Hematological Oncology

Lymphoma Diagnosis and TreatmentReliability and Agreement in Measurement

Cited by 26

LBA65 Efficacy of 177Lu-PNT2002 in PSMA-positive mCRPC following progression on an androgen-receptor pathway inhibitor (ARPI) (SPLASH)

Sartor, O., Jiang, D. M., Smoragiewicz, M., Zibelman, M., Flechon, A., El-Haddad, G., Abikhzer, G., Saad, F., Tutrone, R., Tagawa, S. T., et al. (2024) · Annals of Oncology

Radiopharmaceutical Chemistry and ApplicationsProstate Cancer Treatment and Research

Cited by 23

Administration of Hypoxia-Activated Prodrug Evofosfamide after Conventional Adjuvant Therapy Enhances Therapeutic Outcome and Targets Cancer-Initiating Cells in Preclinical Models of Colorectal Cancer

Haynes, J., McKee, T. D., Haller, A., Wang, Y., Leung, C., Gendoo, D. M. A., Lima-Fernandes, E., Kreso, A., Wolman, R., Szentgyorgyi, E., et al. (2018) · Clinical Cancer Research

Cancer, Hypoxia, and MetabolismCancer Cells and Metastasis

Cited by 22